BMPR2 and pulmonary arterial hypertension: There is compelling evidence that ECFC from pulmonary arterial hypertension patients with BMPR2 mutations exhibit a vasculoproliferative phenotype without the formation of stable vascular networks, highlighting the importance of ECFC in the pathogenesis of PAH [64, 65].